What if you invested $1000 in PEN on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 11 years, Penumbra, Inc. has delivered an average annual return of 22.7%. The stock peaked in 2021 with a massive +63.6% gain, while investors faced a downturn in 2022 (-21.7%). Overall, the stock finished in the green 9 times out of 11 years.
Avg Return
+22.7%
Win Rate
82%
9W - 2L
Best
+63.6%
2021
Worst
-21.7%
2022
Performance Consistency
About Penumbra, Inc.
Visit Website ↗Penumbra is a global healthcare company focused on innovative therapies. It designs, develops, manufactures and markets novel medical devices and has a broad portfolio of products that addresses challenging medical conditions in markets with significant unmet need.
Key Business Segments
Neuro
Devices for ischemic and hemorrhagic stroke.
Vascular
Devices for peripheral vascular conditions (thrombectomy).
Key Innovations
- ✓Aspiration thrombectomy systems (Penumbra System)
- ✓Indigo System for peripheral clots
- ✓REAL Immersive System (VR rehab)
Historical Milestones
Founded by Adam Elsesser and Arani Bose.
IPO on the NYSE.